Evoke Pharma, Inc.

EVOK

$10.69

Name : Evoke Pharma, Inc.

Sector : Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Mark. Cap: $18,412,552.00

EPSttm : -1.25

Evoke Pharma, Inc.

$10.69

0.00%

$0.0000

Float Short %

0.64

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

0.93

EPS This/Next Y

2.56

Price

10.71

Target Price

Analyst Recom

Performance Q

74.39

Relative Volume

0.29

Beta

-0.3

Ticker: EVOK

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-10-20	EVOK	4.66	N/A	N/A	0
2025-10-21	EVOK	4.73	N/A	N/A	0
2025-10-22	EVOK	4.59	N/A	N/A	0
2025-10-23	EVOK	4.66	N/A	N/A	0
2025-10-24	EVOK	4.75	N/A	N/A	0
2025-10-27	EVOK	5.2	N/A	N/A	0
2025-10-28	EVOK	4.9	N/A	N/A	0
2025-10-29	EVOK	5.09	N/A	N/A	0
2025-10-30	EVOK	4.98	N/A	N/A	0
2025-10-31	EVOK	5.15	N/A	N/A	0
2025-11-03	EVOK	4.53	N/A	N/A	0
2025-11-04	EVOK	10.68	N/A	N/A	0
2025-11-05	EVOK	10.66	N/A	N/A	0
2025-11-06	EVOK	10.63	N/A	N/A	0
2025-11-07	EVOK	10.67	N/A	N/A	0
2025-11-10	EVOK	10.69	N/A	N/A	0
2025-11-11	EVOK	10.68	N/A	N/A	0
2025-11-12	EVOK	10.69	N/A	N/A	0
2025-11-13	EVOK	10.69	N/A	N/A	0
2025-11-14	EVOK	10.68	N/A	N/A	0
2025-11-17	EVOK	10.7	N/A	N/A	0
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-10-20	EVOK	4.66	52.1	-	-1.96
2025-10-21	EVOK	4.69	52.1	-	-1.96
2025-10-22	EVOK	4.59	52.1	-	-1.96
2025-10-23	EVOK	4.65	52.1	-	-1.96
2025-10-24	EVOK	4.75	52.1	-	-1.96
2025-10-27	EVOK	5.14	52.1	-	-1.96
2025-10-28	EVOK	4.90	52.1	-	-1.96
2025-10-29	EVOK	5.04	52.1	-	-1.96
2025-10-30	EVOK	5.09	52.1	-	-1.96
2025-10-31	EVOK	5.15	52.1	-	-1.96
2025-11-03	EVOK	4.58	52.1	-	-1.96
2025-11-04	EVOK	10.67	52.1	-	-1.96
2025-11-05	EVOK	10.66	52.1	-	-1.96
2025-11-06	EVOK	10.64	52.1	-	-1.96
2025-11-07	EVOK	10.69	52.1	-	-1.96
2025-11-10	EVOK	10.68	52.1	-	-1.96
2025-11-11	EVOK	10.70	52.1	-	-1.96
2025-11-12	EVOK	10.70	52.1	-	-1.96
2025-11-13	EVOK	10.68	52.1	-	-1.96
2025-11-14	EVOK	10.69	52.1	-	-1.96
2025-11-17	EVOK	10.71	61.0	-	-1.88
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-10-20	EVOK	0.00	12.04	2.92
2025-10-21	EVOK	0.00	12.04	2.92
2025-10-22	EVOK	0.00	12.04	2.92
2025-10-23	EVOK	0.00	12.04	2.92
2025-10-24	EVOK	0.00	12.04	2.92
2025-10-27	EVOK	0.00	13.74	1.20
2025-10-28	EVOK	0.00	13.74	1.20
2025-10-29	EVOK	0.00	13.74	1.20
2025-10-30	EVOK	0.00	13.74	1.20
2025-10-31	EVOK	0.00	13.74	1.20
2025-11-03	EVOK	0.00	12.76	1.20
2025-11-04	EVOK	0.00	12.76	1.20
2025-11-05	EVOK	0.00	12.76	1.20
2025-11-06	EVOK	0.00	12.76	1.20
2025-11-07	EVOK	-9.55	12.76	1.20
2025-11-10	EVOK	-9.55	18.08	1.20
2025-11-11	EVOK	-9.55	18.08	1.20
2025-11-12	EVOK	-9.55	18.08	0.65
2025-11-13	EVOK	-3.39	18.08	0.65
2025-11-14	EVOK	-3.40	18.08	0.64
2025-11-17	EVOK	-3.35	27.56	0.64
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-0.3

Avg. EPS Est. Next Quarter

Insider Transactions

-3.35

Institutional Transactions

27.56

Beta

-0.3

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

98.5

Max Drawdown 5-Year %

-99.7

Target Price

P/E

Forward P/E

15.72

PEG

P/S

1.28

P/B

5.48

P/Free Cash Flow

EPS

-2.38

Average EPS Est. Cur. Y

-1.88

EPS Next Y. (Est.)

0.68

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-36.23

Relative Volume

0.29

Return on Equity vs Sector %

-150

Return on Equity vs Industry %

-130.3

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.08

EBIT Estimation

Evoke Pharma, Inc.

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 3

Evoke Pharma, Inc. operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is based in Solana Beach, California.

stock quote shares EVOK – Evoke Pharma Inc Stock Price stock today

news today EVOK – Evoke Pharma Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch EVOK – Evoke Pharma Inc yahoo finance google finance

stock history EVOK – Evoke Pharma Inc invest stock market

stock prices EVOK premarket after hours

ticker EVOK fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: EVOK

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y